Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

NACompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

June 19, 2020

Primary Completion Date

August 3, 2022

Study Completion Date

August 3, 2022

Conditions
Prenatal DepressionKetaminePostpartum Depression
Interventions
DRUG

S-ketamine

S-ketamine (0.2 mg/kg in 20 ml normal saline) is administered by intravenous infusion in 40 minutes after childbirth.

DRUG

Placebo

Placebo (20 ml normal saline) is administered by intravenous infusion in 40 minutes after childbirth.

Trial Locations (7)

100034

Peking University First Hospital, Beijing

Unknown

Beijing Tiantan Hospital, Beijing

Peking University International Hospital, Beijing

Hunan Provincial Maternal and Child Health Care Hospital, Changsha

Huaian Maternal and Child Health Care Hospital, Huaian

Nanjing Maternal and Child Health Care Hospital, Nanjing

Women's Hospital School Of Medicine Zhejiang University, Hanzhou

Sponsors
All Listed Sponsors
collaborator

Peking University International Hospital

OTHER

collaborator

Hunan Provincial Maternal and Child Health Care Hospital

OTHER

collaborator

Nanjing Medical University

OTHER

collaborator

Women's Hospital School Of Medicine Zhejiang University

OTHER

lead

Peking University First Hospital

OTHER

NCT03927378 - Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression | Biotech Hunter | Biotech Hunter